Related Experiment Videos
Oral immunization against Helicobacter pylori--a future concept
1Division of Gastroenterology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.
Journal of Gastroenterology
|December 5, 1998
Summary
Oral immunization with Helicobacter pylori urease protects mice against H. felis infection. This approach also shows promise as a therapeutic vaccine, with future progress expected in adjuvants, delivery systems, and therapeutic vaccination strategies.
Area of Science:
- * Microbiology and Immunology
- * Vaccine Development
Background:
- * Oral immunization with Helicobacter species lysates or Helicobacter pylori urease demonstrated protective effects against H. felis infection in mice.
- * This breakthrough initiated research into vaccines for Helicobacter infections.
Purpose of the Study:
- * To explore the potential of oral immunization for protection and therapy against Helicobacter infections.
- * To identify additional protective antigens and understand the immune mechanisms involved.
Main Methods:
- * Mice were immunized orally with Helicobacter lysates and H. pylori urease.
- * Efficacy of antigen preparations as both prophylactic and therapeutic vaccines was assessed.
- * Immune responses, including mucosal antibodies and T helper cell activity, were investigated.
Main Results:
- * Oral immunization with specific antigen preparations conferred protection against H. felis infection.
- * The same preparations were effective as therapeutic vaccines, successfully curing the infection.
- * Evidence suggests protection is mediated by mucosal antibodies and a T helper type 2 immune response.
Conclusions:
- * Oral immunization is a viable strategy for both preventing and treating Helicobacter infections.
- * Mucosal antibodies and T helper type 2 responses are key to vaccine-mediated protection.
- * Future advancements are anticipated in vaccine adjuvants, delivery systems, and therapeutic vaccination approaches.